Featured Research

from universities, journals, and other organizations

Evaluating medical research: New treatments better than standard ones just over half the time

Date:
August 27, 2013
Source:
University of South Florida (USF Health)
Summary:
Scientists report that on average new treatments work better than existing ones just over half the time. And, from an ethical and scientific perspective, that's evidence that the randomized controlled trial system is working, they say.

USF Distinguished Professor Benjamin Djulbegovic, MD, PhD, has studied the ethics of randomized clinical trials and their effectiveness in evaluating the outcomes of new treatments for decades.

Related Articles


Now, in a paper published Aug. 22 in the top journal Nature, Dr. Djulbegovic and colleagues report that on average new treatments work better than existing ones just over half the time. On scientific and ethical grounds, they say, the randomized controlled trial (RCT) system's little more than 50-50 success rate over the past half century is evidence that the system is working as intended.

The researchers analyzed 860 phase III published and unpublished RCTs performed by academic institutions or pharmaceutical companies. These trials collectively involved more than 350,000 patients.

"Our retrospective review of more than 50 years of randomized trials shows that they remain the 'indispensable ordeals' through which biomedical researchers' responsibility to patients and the public is manifested," the researchers conclude. "These trials may need tweak and polish, but they're not broken."

People who consent to participate RCTs are willing to be randomly allocated to new or existing treatments. While RCTs are considered the gold standard for comparing the effects of one treatment to another, the gradual progress they yield can seem frustratingly slow -- particularly for patients with poor standard treatment options.

Yet, the genuine uncertainty associated with individual RCTs has been vital to the gains in therapeutics, said Dr. Djulbegovic, professor of medicine and oncology at the USF Health Morsani College of Medicine and Moffitt Cancer Center. If there was significant likelihood that one treatment in a comparison was better than the other, it would be unethical to deny some patients the superior treatment, and well-informed patients would probably refuse to participate in the study, he said.

Incremental advances in treatment generated by RCTs over time -- such as childhood leukemia cure rates moving from zero to 80 percent even though only 2 to 5 percent of new treatments provided a breakthrough -- have translated into important improvements in health and lifespan, the authors say. However, they suggest trials could still benefit from more rigorous design, implementation and reporting -with widespread publication of trial results, including negative findings.

The Nature paper is one of a series of publications that Dr. Djulbegovic and colleagues have authored this year (25 so far), including a clinical therapeutics case study in the New England Journal of Medicine.


Story Source:

The above story is based on materials provided by University of South Florida (USF Health). The original article was written by Anne DeLotto Baier. Note: Materials may be edited for content and length.


Journal Reference:

  1. Benjamin Djulbegovic, Ambuj Kumar, Paul Glasziou, Branko Miladinovic, Iain Chalmers. Medical research: Trial unpredictability yields predictable therapy gains. Nature, 2013; 500 (7463): 395 DOI: 10.1038/500395a

Cite This Page:

University of South Florida (USF Health). "Evaluating medical research: New treatments better than standard ones just over half the time." ScienceDaily. ScienceDaily, 27 August 2013. <www.sciencedaily.com/releases/2013/08/130827122917.htm>.
University of South Florida (USF Health). (2013, August 27). Evaluating medical research: New treatments better than standard ones just over half the time. ScienceDaily. Retrieved November 26, 2014 from www.sciencedaily.com/releases/2013/08/130827122917.htm
University of South Florida (USF Health). "Evaluating medical research: New treatments better than standard ones just over half the time." ScienceDaily. www.sciencedaily.com/releases/2013/08/130827122917.htm (accessed November 26, 2014).

Share This


More From ScienceDaily



More Science & Society News

Wednesday, November 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Who Will Failed Nuclear Talks Hurt Most?

Who Will Failed Nuclear Talks Hurt Most?

Reuters - Business Video Online (Nov. 25, 2014) With no immediate prospect of sanctions relief for Iran, and no solid progress in negotiations with the West over the country's nuclear programme, Ciara Lee asks why talks have still not produced results and what a resolution would mean for both parties. Video provided by Reuters
Powered by NewsLook.com
FCC Forces T-Mobile To Alert Customers Of Data Throttling

FCC Forces T-Mobile To Alert Customers Of Data Throttling

Newsy (Nov. 25, 2014) T-Mobile and the FCC have reached an agreement requiring the company to alert customers when it throttles their data speeds. Video provided by Newsy
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Symantec Uncovers Sophisticated Spying Malware Regin

Symantec Uncovers Sophisticated Spying Malware Regin

Newsy (Nov. 24, 2014) A Symantec white paper reveals details about Regin, a spying malware of unusual complexity which is believed to be state-sponsored. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Science & Society

Business & Industry

Education & Learning

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins